Arvinas Ownership | Who Owns Arvinas?

Overview Forecast RevenueFinancials Chart Transcripts

Arvinas Ownership Summary

Arvinas is owned by 87.53% institutional investors, 7.80% insiders, and 4.66% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.89% of ARVN shares. BB Biotech AG Ord is the top mutual fund, with 3.46% of its assets in Arvinas shares.

ARVN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Arvinas	87.53%	7.80%	4.66%
Sector	Healthcare Stocks	50.50%	12.33%	37.17%
Industry	Biotech Stocks	49.09%	12.06%	38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	7.61M	11.89%	$63.23M
Vanguard group	7.23M	9.92%	$85.74M
Blackrock	6.26M	8.70%	$166.61M
Logos global management lp	5.58M	7.66%	$47.50M
D. e. shaw	3.50M	5.46%	$29.04M
Pfizer	3.46M	5.40%	$27.66M
Armistice capital	2.80M	4.37%	$23.23M
Vanguard capital management	2.71M	4.24%	$22.55M
Two sigma investments, lp	2.57M	4.02%	$21.39M
State street	2.20M	3.43%	$18.26M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	1.59M	31.38%	$13.51M
Pfizer	3.46M	16.24%	$27.66M
Aquilo capital management	328.77K	9.50%	$6.30M
Nextech invest	1.41M	4.38%	$27.00M
Logos global management lp	5.58M	4.26%	$47.50M
Rangeley capital	175.59K	1.33%	$1.46M
Arbiter partners capital management	294.59K	1.29%	$2.45M
Opaleye management	987.82K	1.19%	$8.42M
Boxer capital	608.61K	0.85%	$16.20M
Nextech invest	1.12M	0.81%	$17.12M

Top Buyers

Holder	Shares	% Assets	Change
Logos global management lp	5.58M	4.26%	2.27M
Norges bank	1.24M	0.00%	1.24M
Armistice capital	2.80M	0.28%	818.00K
Blackrock funding, inc. /de	7.61M	0.00%	811.54K
Blackrock	6.26M	0.00%	764.55K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	-	-	-6.73M
Rtw investments, lp	-	-	-3.33M
Bellevue group	-	-	-2.39M
Paradigm biocapital advisors lp	-	-	-2.34M
Alyeska investment group	-	-	-1.80M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.24M	0.00%	1.24M	$23.84M
Hillsdale investment management	750.90K	0.14%	750.90K	$6.24M
Sixth street partners management company	542.17K	0.00%	542.17K	$4.51M
Renaissance	215.34K	0.00%	215.34K	$1.79M
Occudo quantitative strategies lp	124.65K	0.06%	124.65K	$1.04M

Sold Out

Holder	Change
Hughes financial services	-1.00
Truvestments capital	-1.00
Capital performance advisors llp	-6.00
Turning point benefit group	-7.00
Smartleaf asset management	-8.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	203	-3.79%	56,021,993	3.53%	87	1.22%	115	18.56%	50	-29.58%
Mar 31, 2026	77	-63.16%	11,747,414	-78.99%	18	0.31%	39	-60.20%	19	-73.61%
Dec 31, 2025	124	-44.14%	33,193,014	-50.49%	45	0.54%	57	-47.22%	41	-40.58%
Sep 30, 2025	210	-4.98%	63,374,662	4.16%	87	1.25%	101	-20.47%	66	29.41%
Jun 30, 2025	229	1.33%	69,799,900	12.46%	95	1.31%	130	2.36%	52	-10.34%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	2.38M	3.46%	-
Vanguard Total Stock Mkt Idx Inv	1.92M	2.98%	-
Vanguard Morn Total Stk Mkt Idx Investor	1.92M	2.98%	-
Vanguard US Total Market Shares ETF	1.93M	2.81%	2.43K
Vanguard Strategic Equity Inv	1.71M	2.65%	90.35K
iShares Russell 2000 ETF	1.52M	2.32%	-26.98K
Vanguard Explorer Inv	896.37K	1.39%	-
Vanguard Small Cap Index	841.18K	1.15%	-5.64K
Vanguard Institutional Extnd Mkt Idx Tr	727.13K	1.13%	2.79K
State Street® SPDR® S&P® PhrmctlsETF	728.88K	1.11%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 24, 2026	Saik Andrew	Chief Financial Officer	Sell	$46.47K
Jun 17, 2026	Cacace Angela M	Chief Scientific Officer	Sell	$19.56K
May 21, 2026	Teel Randy	President and CEO	Sell	$19.96K
May 11, 2026	Saik Andrew	Chief Financial Officer	Sell	$110.69K
May 11, 2026	Loomis David K	VP, Chief Accounting Officer	Sell	$19.07K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	8
2026 Q1	1	14
2025 Q4	-	1
2025 Q3	1	-
2025 Q2	-	2

ARVN Ownership FAQ

Who Owns Arvinas?

Arvinas shareholders are primarily institutional investors at 87.53%, followed by 7.80% insiders and 4.67% retail investors. The average institutional ownership in Arvinas's industry, Biotech Stocks , is 49.09%, which Arvinas exceeds.

Who owns the most shares of Arvinas?

Arvinas’s largest shareholders are Blackrock funding, inc. /de (7.61M shares, 11.89%), Vanguard group (7.23M shares, 9.92%), and Blackrock (6.26M shares, 8.70%). Together, they hold 30.51% of Arvinas’s total shares outstanding.

Does Blackrock own Arvinas?

Yes, BlackRock owns 8.70% of Arvinas, totaling 6.26M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 166.61M$. In the last quarter, BlackRock increased its holdings by 764.55K shares, a 13.92% change.

Who is Arvinas’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Arvinas’s biggest shareholder by percentage of total assets invested, with 31.38% of its assets in 1.59M Arvinas shares, valued at 13.51M$.

Who is the top mutual fund holder of Arvinas shares?

BB Biotech AG Ord is the top mutual fund holder of Arvinas shares, with 3.46% of its total shares outstanding invested in 2.38M Arvinas shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools